Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients.

Hemasphere · 2026 · PMC13058923 · PMID 41959729

Europe PMC DOI

hedged sentence

0.1690

closest p · 3.4× alpha

0.1690

boldest claim

The sentences

did not reach statistical significanceP = 0.169not close (p > 0.1)

Preinfusion leptomeningeal or parenchymal enhancement was present in 10% more children who developed severe versus no/mild neurotoxicity but did not reach statistical significance (P = 0.169).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.